Home › Funds › Blue Owl Capital Holdings LP › ARTV
Blue Owl Capital Holdings LP position in ARTV
ARTIVA BIOTHERAPEUTICS INC · Health Care
Blue Owl Capital Holdings LP reported holding 4,126,322 shares of ARTV (ARTIVA BIOTHERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$63.8M, representing 12.00% of its reported portfolio and ranking #3 among its reported holdings. Blue Owl Capital Holdings LP has disclosed ARTV holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Blue Owl Capital Holdings LP's ARTV position evolved
Blue Owl Capital Holdings LP first disclosed a stake in ARTV in Q2 2026 at 874,542 shares (US$8.5M). The position peaked in Q3 2026 at 4,126,322 shares, worth US$63.8M. Across 2 filings, Blue Owl Capital Holdings LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 4,126,322 shares valued at US$63.8M — an increase of 3,251,780 shares quarter over quarter.. Notable position changes include a 372% increase in Q3 2026 (shares fell 43% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 874.54K | $8.48M | New |
| Q3 2026 | 4.13M | $63.84M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ARTV and 13F data
ARTV (ARTIVA BIOTHERAPEUTICS INC) is a Health Care company. 70 other funds we track also report a position in ARTV — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$174.2M), 5AM Venture Management, LLC (US$22.8M), Venrock Adviser, LLC (US$19.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ARTV
- RA CAPITAL MANAGEMENT, L.P. 17.96M sh · $174.17M · Q2 2026
- 5AM Venture Management, LLC 2.35M sh · $22.83M · Q2 2026
- Venrock Adviser, LLC 2.04M sh · $19.82M · Q2 2026
- Caligan Partners LP 1.74M sh · $16.84M · Q2 2026
- Sanofi 672.78K sh · $11.24M · Q3 2026
- Samsara BioCapital, LLC 954.86K sh · $9.26M · Q2 2026
- Propel Bio Management, LLC 696.44K sh · $4.96M · Q3 2026
- ACUTA CAPITAL PARTNERS, LLC 260.42K sh · $2.53M · Q2 2026
- Revelation Capital Management, LLC 299.31K sh · $2.13M · Q3 2026
- KVP Capital Advisors, LP 200.00K sh · $1.94M · Q2 2026
- CRCM LP 25.39K sh · $423.95K · Q3 2026
- Velan Capital Investment Management LP 25.00K sh · $242.50K · Q2 2026
More on Blue Owl Capital Holdings LP
FAQ
How long has Blue Owl Capital Holdings LP held ARTV?
Blue Owl Capital Holdings LP has disclosed ARTV holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Blue Owl Capital Holdings LP's current position in ARTV?
As of Q3 2026, Blue Owl Capital Holdings LP holds 4.13M shares of ARTV (ARTIVA BIOTHERAPEUTICS INC), valued at $63.84M, representing 12.00% of its reported portfolio and ranking #3.
Has Blue Owl Capital Holdings LP been buying or selling ARTV?
In the latest 13F filing (Q3 2026), Blue Owl Capital Holdings LP increased its position in ARTV. The position peaked in Q3 2026 at 4.13M shares.
Which other funds hold ARTV?
Other major institutional holders of ARTV include RA CAPITAL MANAGEMENT, L.P., 5AM Venture Management, LLC, Venrock Adviser, LLC, among 70 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.